Parkinson's disease. First of two parts - PubMed (original) (raw)

Review

Parkinson's disease. First of two parts

A E Lang et al. N Engl J Med. 1998.

No abstract available

PubMed Disclaimer

Similar articles

• Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders".
  Parkkinen L, Silveira-Moriyama L, Holton JL, Lees AJ, Revesz T. Parkkinen L, et al. Acta Neuropathol. 2009 Feb;117(2):213-4; author reply 217-8. doi: 10.1007/s00401-008-0462-3. Epub 2008 Nov 25. Acta Neuropathol. 2009. PMID: 19031077 No abstract available.
• [Dementia with Lewy bodies and Parkinson's disease with dementia].
  Shinotoh H. Shinotoh H. Rinsho Shinkeigaku. 1999 Nov;39(11):1171-2. Rinsho Shinkeigaku. 1999. PMID: 10689946 Japanese. No abstract available.
• Neuropathology of Lewy body disorders.
  Kövari E, Horvath J, Bouras C. Kövari E, et al. Brain Res Bull. 2009 Oct 28;80(4-5):203-10. doi: 10.1016/j.brainresbull.2009.06.018. Epub 2009 Jul 1. Brain Res Bull. 2009. PMID: 19576266 Review.
• The neuromythology of Parkinson's Disease.
  Calne DB, Mizuno Y. Calne DB, et al. Parkinsonism Relat Disord. 2004 Jul;10(5):319-22. doi: 10.1016/j.parkreldis.2004.03.006. Parkinsonism Relat Disord. 2004. PMID: 15196512 Review.
• Dementia with Lewy bodies.
  Lennox GG, Lowe JS. Lennox GG, et al. Baillieres Clin Neurol. 1997 Apr;6(1):147-66. Baillieres Clin Neurol. 1997. PMID: 9426873 Review.

Cited by

• The use of next-generation sequencing in movement disorders.
  Krebs CE, Paisán-Ruiz C. Krebs CE, et al. Front Genet. 2012 May 14;3:75. doi: 10.3389/fgene.2012.00075. eCollection 2012. Front Genet. 2012. PMID: 22593763 Free PMC article.
• Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant.
  Koh H, Kim H, Kim MJ, Park J, Lee HJ, Chung J. Koh H, et al. J Biol Chem. 2012 Apr 13;287(16):12750-8. doi: 10.1074/jbc.M111.337907. Epub 2012 Feb 29. J Biol Chem. 2012. PMID: 22378780 Free PMC article.
• Secondary Parkinsonism in a Patient With a Cerebral Cavernous Hemangioma Treated With Stereotactic Radiosurgery.
  Aydin S, Esen Aydin A, Yuksel O, Tanriverdi T. Aydin S, et al. Cureus. 2021 Mar 26;13(3):e14128. doi: 10.7759/cureus.14128. Cureus. 2021. PMID: 33927936 Free PMC article.
• Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model.
  Xie L, Hu LF, Teo XQ, Tiong CX, Tazzari V, Sparatore A, Del Soldato P, Dawe GS, Bian JS. Xie L, et al. PLoS One. 2013;8(4):e60200. doi: 10.1371/journal.pone.0060200. Epub 2013 Apr 3. PLoS One. 2013. PMID: 23573240 Free PMC article.
• Clinical Characteristics of Patients with De Novo Parkinson's Disease and a Positive Family History.
  Kim H, Choi SM, Lee HL, Cho SH, Kim BC. Kim H, et al. Medicina (Kaunas). 2024 Aug 23;60(9):1378. doi: 10.3390/medicina60091378. Medicina (Kaunas). 2024. PMID: 39336419 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information